A straightforward guide to the sarcomeric basis of cardiomyopathies

Luís R Lopes1, Perry M Elliott2

  • 1Institute of Cardiovascular Science, University College London, London, UK Centro de Cardiologia da Universidade de Lisboa, University of Lisbon, Lisbon, Portugal Cardiology Department, Hospital Garcia de Orta, Almada, Portugal.

Insights

Genetic mutations in sarcomeric proteins cause cardiomyopathies. Understanding sarcomere structure and function aids in identifying new gene targets and developing disease-modifying drugs for these muscle disorders.

Area of Science:

  • Muscle physiology
  • Cardiovascular genetics
  • Molecular biology

Background:

  • The sarcomere is the fundamental contractile unit in striated muscle.
  • Mutations in sarcomeric protein genes lead to various cardiomyopathies, including hypertrophic, dilated, restrictive, and ventricular non-compaction.
  • These genetic defects trigger diverse molecular pathways, affecting muscle function and leading to disease.

Purpose of the Study:

  • To explore the link between sarcomeric protein mutations and cardiomyopathies.
  • To understand the molecular mechanisms underlying disease phenotypes.
  • To identify potential therapeutic targets for cardiomyopathy treatment.

Main Methods:

  • Review of genetic studies on sarcomeric proteins.
  • Analysis of molecular pathways affected by sarcomeric mutations.
  • Investigation of structure-function relationships within the sarcomere.

Main Results:

  • Sarcomeric protein gene mutations are a primary cause of diverse cardiomyopathies.
  • Downstream effects include altered acto-myosin kinetics, mechanosensation, calcium handling, signaling, energetics, ischemia, and fibrosis.
  • Genetic insights have improved understanding of sarcomere structure and function.

Conclusions:

  • Elucidating genetic causes of cardiomyopathy enhances knowledge of sarcomere biology.
  • Detailed understanding of sarcomeres and associated proteins suggests new candidate genes.
  • Advances offer hope for developing novel disease-modifying drugs for cardiomyopathies.

Related Concept Videos

Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
809
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
795
Structure of Cardiac Muscles01:13

Structure of Cardiac Muscles

Cardiac muscle, or myocardium, is a specialized type of muscle found exclusively in the heart. Its unique structural and functional characteristics enable the heart to perform its vital role of pumping blood throughout the body continuously and rhythmically. The cardiac muscle cells, or cardiomyocytes, possess an endomysium and perimysium but do not have an epimysium.
Compared to skeletal muscles, cardiac muscle cells are small and mostly have a single nucleus. Additionally, they are usually...
16.3K
The Sarcomere01:08

The Sarcomere

A sarcomere is a microscopic segment repeating in a myofibril. The sarcomere fundamentally consists of two main myofilaments: thick filaments called myosin and thin filaments called actin. These filaments interact by sliding past each other in response to stimulus. In addition to myosin and actin, several other proteins, such as tropomyosin, troponin, titin, nebulin, myomesin, α-actinin, and dystrophin, play crucial roles in regulating, structuring, and functioning of the sarcomere.
Each...
17.9K
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
930
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
767